Smith & Nephew plc (SNN), Wednesday encouraging results for its CARTIHEAL AGILI-C Cartilage Repair Implant for the treatment of knee cartilage defects.
The recent multicentre randomised controlled trial found that participants treated with CARTIHEAL AGILI-C Implant experienced significantly better knee pain relief, improvements in quality of life over a four-year period, and superior improvements in performing activities.
Additionally, the implant reduced the risk of subsequent total knee arthroplasty and osteotomy by 87 percent in patients compared to the surgical standard of care.
In the pre-market hours, Smith & Nephew's stock is trading at $28.17, down 0.95 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.